Literature DB >> 16520825

Pharmacogenomics and lung transplantation: clinical implications.

G J Burckart1, I V Hutchinson, A Zeevi.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16520825     DOI: 10.1038/sj.tpj.6500376

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  4 in total

1.  Immunosuppression for Lung Transplantation: Current and Future.

Authors:  Satish Chandrashekaran; Stacy A Crow Pharm; Sadia Z Shah; Chris J Arendt Pharm; Cassie C Kennedy
Journal:  Curr Transplant Rep       Date:  2018-07-13

2.  Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid.

Authors:  Laneshia K Tague; Derek E Byers; Ramsey Hachem; Daniel Kreisel; Alexander S Krupnick; Hrishikesh S Kulkarni; Catherine Chen; Howard J Huang; Andrew Gelman
Journal:  Pharmacogenomics J       Date:  2019-04-17       Impact factor: 3.550

3.  Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation.

Authors:  Jesus Ruiz; María José Herrero; Virginia Bosó; Juan Eduardo Megías; David Hervás; Jose Luis Poveda; Juan Escrivá; Amparo Pastor; Amparo Solé; Salvador Francisco Aliño
Journal:  Int J Mol Sci       Date:  2015-08-25       Impact factor: 5.923

Review 4.  Immunosuppressive strategies in lung transplantation.

Authors:  Paul A Chung; Daniel F Dilling
Journal:  Ann Transl Med       Date:  2020-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.